Literature DB >> 15887267

Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality.

Christiane Hitz1, Daniela Vogt-Weisenhorn, Patricia Ruiz, Wolfgang Wurst, Thomas Floss.   

Abstract

We have generated a mouse line with a mutant allele of the mouse Bruce/Birc6 gene induced by gene trap mutagenesis. Based on its structural features, Bruce is a member of the family of apoptosis inhibitor proteins (IAPs). This mutation leads to a truncated transcript and protein and results in a complete loss of the wildtype Bruce protein. Bruce mutant mice die from a progressive loss of their placental spongiotrophoblast layer between day 11.5 and 14.5 of embryonic development. The cause of the Bruce homozygous mutant phenotype is a lack of proliferation of spongiotrophoblast cells in the developing placenta. In contrast to in vitro data, which indicate a function for Bruce in apoptosis inhibition, the in vivo results presented here suggest instead a role for Bruce in cell division. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887267     DOI: 10.1002/gene.20128

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  11 in total

1.  Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta.

Authors:  Shin Matsubara; Takayuki Takahashi; Atsushi P Kimura
Journal:  J Mol Histol       Date:  2011-05-05       Impact factor: 2.611

Review 2.  Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation.

Authors:  Mary X D O'Riordan; Laura D Bauler; Fiona L Scott; Colin S Duckett
Journal:  Dev Cell       Date:  2008-10       Impact factor: 12.270

3.  APOLLON protein promotes early mitotic CYCLIN A degradation independent of the spindle assembly checkpoint.

Authors:  Ryo Kikuchi; Hirokazu Ohata; Nobumichi Ohoka; Atsushi Kawabata; Mikihiko Naito
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

4.  Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents.

Authors:  Jason B Garrison; Chunmin Ge; Lixiao Che; Derek A Pullum; Guang Peng; Sohaib Khan; Nira Ben-Jonathan; Jiang Wang; Chunying Du
Journal:  J Cancer Sci Ther       Date:  2015-04

5.  The imprinted Phlda2 gene modulates a major endocrine compartment of the placenta to regulate placental demands for maternal resources.

Authors:  S J Tunster; H D J Creeth; R M John
Journal:  Dev Biol       Date:  2015-10-23       Impact factor: 3.582

6.  Scanning of selection signature provides a glimpse into important economic traits in goats (Capra hircus).

Authors:  Dailu Guan; Nanjian Luo; Xiaoshan Tan; Zhongquan Zhao; Yongfu Huang; Risu Na; Jiahua Zhang; Yongju Zhao
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

7.  BIRC6 mediates imatinib resistance independently of Mcl-1.

Authors:  Denis O Okumu; Michael P East; Merlin Levine; Laura E Herring; Raymond Zhang; Thomas S K Gilbert; David W Litchfield; Yanping Zhang; Lee M Graves
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

8.  Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis.

Authors:  Lixiao Che; Xingyuan Yang; Chunmin Ge; Salim S El-Amouri; Qi-En Wang; Dao Pan; Thomas J Herzog; Chunying Du
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

Review 9.  Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions.

Authors:  Ömer Güllülü; Stephanie Hehlgans; Claus Rödel; Emmanouil Fokas; Franz Rödel
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.639

10.  Isolating the role of elevated Phlda2 in asymmetric late fetal growth restriction in mice.

Authors:  Simon J Tunster; Mathew Van De Pette; Rosalind M John
Journal:  Dis Model Mech       Date:  2014-08-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.